Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community

Summary

To inform a future randomized trial of a virtual counselor led computer delivered intervention for tobacco cessation augmented with community health worker (CHW) support and navigation to lung cancer screening in low-income housing units in Baltimore, the investigators propose to collect data on intervention acceptability and feasibility among individuals in public housing as well as feedback on use of shared decision making when referring for low-dose chest CT (LDCT).

The investigators will conduct a feasibility pilot study of a virtual counselor plus community health worker intervention. With a sample of participants from public housing units (N=15), the investigators will collect data on feasibility of recruitment, intervention engagement and completion, and short-term smoking cessation outcomes. Individuals will be assessed at baseline, 1 month and 3 months. At the end of three months, the investigators will conduct follow up interviews with a subset of pilot participants to collect qualitative data on intervention acceptability. Based on this information, the investigators will make iterative improvements to the combined intervention.

Conditions

• Tobacco Dependence

Interventions

BEHAVIORAL

C-Raven Virtual Tobacco Cessation Counseling

A two-module tobacco cessation intervention that involves interaction with a virtual counselor and includes instruction about addiction and the use of pharmacotherapy for cessation. Each module takes approximately 20 minutes to complete.

DRUG

Nicotine Replacement Product

Participants will be offered a 12-week supply of nicotine patches and either nicotine gum or lozenges.

OTHER

Community Health Worker

A community health worker will meet with each participant throughout the study period to teach appropriate NRT usage, discuss barriers/facilitators to NRT use and cessation, conduct shared decision-making about lung cancer screening, and provide health system navigation when needed.

OTHER

Lung Cancer Screening

Eligible participants will be referred to their primary care physician or existing specialist to complete lung cancer screening.

Sponsors & Collaborators

• Maryland Cigarette Restitution Fund

  collaborator OTHER_GOV

• Johns Hopkins University

  lead OTHER

Principal Investigators

• Jeanne Clark, MD · Johns Hopkins School of Medicine

Study Design

Allocation

NA

Purpose

TREATMENT

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

50 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-04-30

Primary Completion

2024-08-23

Completion

2024-08-27

FDA Drug

Yes

Countries

• United States

Study Locations